| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $8.8M | +6.3% | -7.9% |
| Cost of Revenue | $4.4M | -1.6% | -5.3% |
| Gross Profit | $4.4M | +15.7% | -10.4% |
| R&D Expense | $5.7M | -4.6% | -31.9% |
| SG&A Expense | $4.3M | -3.8% | -14.8% |
| Operating Income | -$5.6M | +23.0% | +34.9% |
| Pre-tax Income | -$5.1M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $14.6M | +2.5% | -49.3% |
| Accounts Receivable | $5.7M | +12.2% | +26.4% |
| Inventory | $3.1M | -22.9% | -28.4% |
| Current Assets | $25.3M | -1.0% | -36.2% |
| Total Assets | $50.5M | -2.5% | -29.0% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$14.1M | — | — |
| Capital Expenditures | $403K | — | — |
| Investing Cash Flow | $351K | — | — |
| Financing Cash Flow | $4.7M | — | — |
| Free Cash Flow | -$14.5M | — | — |
| +20.7% |
| +38.8% |
| Income Tax | -$511K | -204.1% | -508.8% |
| Net Income | -$4.4M | +33.9% | +45.6% |
| EPS (Basic) | -$0.81 | +36.2% | -478.6% |
| EPS (Diluted) | -$0.81 | +36.2% | -478.6% |
| $9.8M |
| +6.9% |
| -1.3% |
| Total Liabilities | $23.6M | +0.6% | -12.5% |
| Stockholders' Equity | -$23.9M | -6.7% | -198.1% |